Innospec Inc. (NASDAQ:IOSP) Short Interest Update

Innospec Inc. (NASDAQ:IOSP - Get Free Report) was the target of a significant growth in short interest during the month of August. As of August 15th, there was short interest totalling 257,500 shares, a growth of 16.0% from the July 31st total of 221,900 shares. Currently, 1.1% of the company's stock are sold short. Based on an average trading volume of 128,700 shares, the short-interest ratio is currently 2.0 days.Insider Transactions at InnospecIn related news, CFO Ian Cleminson sold 3,398 shares of Innospec stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $114.74, for a total value of $389,886.52. Following the completion of the sale, the chief financial officer now directly owns 12,996 shares in the company, valued at approximately $1,491,161.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.52% of the company's stock. Hedge Funds Weigh In On InnospecInstitutional investors have recently modified their holdings of the stock. TFO Wealth Partners LLC grew its holdings in Innospec by 29,800.0% during the fourth quarter. TFO Wealth Partners LLC now owns 299 shares of the specialty chemicals company's stock worth $37,000 after acquiring an additional 298 shares during the period. GAMMA Investing LLC acquired a new stake in shares of Innospec during the 4th quarter worth approximately $44,000. DekaBank Deutsche Girozentrale purchased a new position in shares of Innospec during the 1st quarter valued at approximately $66,000. CWM LLC lifted its stake in shares of Innospec by 239.6% in the 2nd quarter. CWM LLC now owns 635 shares of the specialty chemicals company's stock valued at $78,000 after purchasing an additional 448 shares during the period. Finally, Motco purchased a new stake in Innospec during the first quarter worth $132,000. Hedge funds and other institutional investors own 96.64% of the company's stock. Innospec Stock Up 1.2 %Shares of NASDAQ IOSP opened at $115.26 on Monday. Innospec has a 52 week low of $95.69 and a 52 week high of $133.71. The business's 50 day moving average price is $119.68 and its 200 day moving average price is $123.31. The firm has a market cap of $2.87 billion, a P/E ratio of 19.57 and a beta of 1.10. Innospec (NASDAQ:IOSP - Get Free Report) last released its quarterly earnings data on Tuesday, August 6th. The specialty chemicals company reported $1.39 earnings per share for the quarter, topping analysts' consensus estimates of $1.37 by $0.02. The firm had revenue of $435.00 million for the quarter, compared to analyst estimates of $468.73 million. Innospec had a net margin of 7.90% and a return on equity of 14.15%. The business's quarterly revenue was down 9.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.28 earnings per share. As a group, research analysts expect that Innospec will post 5.95 earnings per share for the current year. Analyst Upgrades and DowngradesSeparately, StockNews.com downgraded Innospec from a "strong-buy" rating to a "buy" rating in a research note on Thursday, August 8th.View Our Latest Analysis on InnospecInnospec Company Profile (Get Free Report)Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.Read MoreFive stocks we like better than InnospecHow to Choose Top Rated StocksAutodesk Stock: Analysts' Top AI Pick You Shouldn’t OverlookHow to Use the MarketBeat Dividend CalculatorHidden Opportunities in Li Auto’s Tough Quarter You Can’t MissAre Penny Stocks a Good Fit for Your Portfolio?Don’t Overlook Campbell Soup: Here’s What Could Drive Its StockThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.→ 625,000% Gain (From Crypto Swap Profits) (Ad)Should you invest $1,000 in Innospec right now?Before you consider Innospec, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.While Innospec currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here